Need help finding what you are looking for?
Contact Us
PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1371511
PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1371511
Pharma Contract Sales Market Report 2023-2033
PUBLISHED:
PAGES: 304 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global Pharma Contract Sales market is projected to grow at a CAGR of 8.2% by 2033.
“The Pharma Contract Sales Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Global Players Consolidating CRO and CSO Operations to Offer End-to-end Services
Major industry players are integrating Contract Research Organization (CRO) and Contract Sales Organization (CSO) operations, resulting in significant benefits. Several prominent CRO providers have effectively combined their services with commercialization capabilities through mergers and acquisitions (M&A), enabling them to offer comprehensive solutions to clients across the drug development journey.
Notable instances of such strategic moves include INC Research's acquisition and subsequent rebranding as Syneos, as well as Quintiles' acquisition of IMS. Similarly, in January 2023, Publicis Groupe recently revealed their acquisition of Advertise BG, a prominent performance marketing agency in Bulgaria. This strategic move aims to enhance Publicis Groupe Bulgaria's capabilities in digital transformation, bolstering their services in digital strategy, data analytics, social media management, and digital content production.
This trend towards consolidation and integration within the CRO and CSO landscape is expected to fuel the demand for contract sales services. The seamless integration of research, development, and commercialization services facilitates a more streamlined and efficient drug development process. Clients seeking a holistic and efficient approach are likely to increasingly turn to providers offering end-to-end solutions, further stimulating the demand for contract sales services.
Growing Demand for Pharma Contract Sales Services
In recent years, the pharmaceutical industry has witnessed a significant transformation marked by diversification and specialization. This evolution has led to an increased demand for pharma contract sales services worldwide. As pharmaceutical companies expand their product portfolios to encompass a broader range of therapeutic areas, they face the challenge of effectively promoting and distributing these diverse offerings.
Pharma contract sales services provide a strategic solution by offering specialized sales teams and tailored marketing strategies. These services allow pharmaceutical companies to access experienced professionals with deep industry knowledge and networks, enabling efficient market penetration for their varied product lines. Additionally, the cost-effectiveness and flexibility offered by contract sales services make them an attractive option for companies looking to optimize resource allocation.
Furthermore, globalization has expanded market reach, requiring companies to adapt to various regulatory environments and market dynamics. Pharma contract sales services facilitate this adaptation by providing local expertise and understanding of regional markets, ensuring compliance and effective engagement with healthcare professionals.
In conclusion, the diversification of the pharmaceutical industry has heightened the need for agile and specialized sales and marketing approaches. Pharma contract sales services have emerged as a crucial tool in meeting these evolving demands, ultimately enhancing the industry's ability to effectively reach and serve diverse markets.
What Questions Should You Ask before Buying a Market Research Report?
- How is the Pharma Contract Sales market evolving?
- What is driving and restraining the Pharma Contract Sales market?
- How will each Pharma Contract Sales submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each Pharma Contract Sales submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading Pharma Contract Sales markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Pharma Contract Sales projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of Pharma Contract Sales projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the Pharma Contract Sales market?
- Where is the Pharma Contract Sales market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Pharma Contract Sales market today, and over the next 10 years:
- Our 304-page report provides 128 tables and 172 charts/graphs exclusively to you
- The report highlights key lucrative areas in the industry so you can target them - NOW
- It contains in-depth analysis of global, regional and national sales and growth
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Pharma Contract Sales market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
- In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
- You will find original analyses, with business outlooks and developments
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Pharma Contract Sales prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report:
Type
- Personal Promotion
- Promotional Sales Team
- Vacancy Management
- Health Care Professional
- Non-personal Promotion
- Contact Centre
- Tele-detailing
- Medical Call Centres
- Telesampling
- Online Services
- Co-promotion
- Marketing Research and Consulting
- Product Commercialization
- Territory Optimization and Alignment
- Brand Management
- Mature Product Line Support
- Rest All CSO Services
Therapeutics
- Oncology
- Immunology
- Diabetes
- Cardiovascular Disease
- Respiratory
- CNS
- Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:
North America
- U.S
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
The report also includes profiles and for some of the leading companies in the Pharma Contract Sales Market, 2023 to 2033, with a focus on this segment of these companies' operations.
Leading companies profiled in the report:
|
|
Overall world revenue for Pharma Contract Sales Market, 2023 to 2033 in terms of value the market will surpass US$7,600 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Pharma Contract Sales Market, 2023 to 2033 report help you?
In summary, our 300+ page report provides you with the following knowledge:
- Revenue forecasts to 2033 for Pharma Contract Sales Market, 2023 to 2033 Market, with forecasts for type and therapeutics each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 21 key national markets - See forecasts for the Pharma Contract Sales Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 18 of the major companies involved in the Pharma Contract Sales Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Pharma Contract Sales Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Product Code: PHA1294
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Pharma Contract Sales Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 Growing Significance of Data in Pharma to Drive the Market Demand
- 3.2.1.2 Global Players Consolidating CRO and CSO Operations to Offer End-to-end Services
- 3.2.1.3 Transforming Pharma Sales: Technology and Outsourcing in the Pharmaceutical Services Industry
- 3.2.2 Market Restraining Factors
- 3.2.2.1 Quality Challenges in the Competitive Contract Pharma Services Market
- 3.2.2.2 Navigating Regulatory Hurdles and Timelines in Pharmaceutical Contract Manufacturing
- 3.2.3 Market Opportunities
- 3.2.3.1 Rising Opportunities for Pharmaceutical Expansion in Asian Markets
- 3.2.3.2 Diversification Trends in the Pharma Industry: Increasing Inorganic and Organic Activities to Create Market Opportunities
- 3.2.1 Market Driving Factors
- 3.3 COVID-19 Impact Analysis
- 3.4 Porter's Five Forces Analysis
- 3.4.1 Bargaining Power of Suppliers
- 3.4.2 Bargaining Power of Buyers
- 3.4.3 Competitive Rivalry
- 3.4.4 Threat from Substitutes
- 3.4.5 Threat of New Entrants
- 3.5 PEST Analysis
4 Pharma Contract Sales Market Analysis by Type
- 4.1 Key Findings
- 4.2 Type Segment: Market Attractiveness Index
- 4.3 Pharma Contract Sales Market Size Estimation and Forecast by Type
- 4.4 Personal Promotion
- 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.4.3 Promotional Sales Team
- 4.4.3.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.4.3.2 Market Share by Region, 2023 & 2033 (%)
- 4.4.4 Vacancy Management
- 4.4.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.4.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.4.5 Health Care Professional
- 4.4.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.4.5.2 Market Share by Region, 2023 & 2033 (%)
- 4.5 Non-personal Promotion
- 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.5.2 Market Share by Region, 2023 & 2033 (%)
- 4.5.3 Contact Centre
- 4.5.3.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.5.3.2 Market Share by Region, 2023 & 2033 (%)
- 4.5.4 Tele-detailing
- 4.5.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.5.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.5.5 Medical Call Centres
- 4.5.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.5.5.2 Market Share by Region, 2023 & 2033 (%)
- 4.5.6 Telesampling
- 4.5.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.5.6.2 Market Share by Region, 2023 & 2033 (%)
- 4.5.7 Online Services
- 4.5.7.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.5.7.2 Market Share by Region, 2023 & 2033 (%)
- 4.6 Co-promotion
- 4.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.6.2 Market Share by Region, 2023 & 2033 (%)
- 4.6.3 Marketing Research and Consulting
- 4.6.3.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.6.3.2 Market Share by Region, 2023 & 2033 (%)
- 4.6.4 Product Commercialization
- 4.6.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.6.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.6.5 Territory Optimization & Alignment
- 4.6.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.6.5.2 Market Share by Region, 2023 & 2033 (%)
- 4.6.6 Brand Management
- 4.6.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.6.6.2 Market Share by Region, 2023 & 2033 (%)
- 4.6.7 Mature Product Line Support
- 4.6.7.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.6.7.2 Market Share by Region, 2023 & 2033 (%)
- 4.6.8 Rest All CSO Services
- 4.6.8.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.6.8.2 Market Share by Region, 2023 & 2033 (%)
5 Pharma Contract Sales Market Analysis by Therapeutics
- 5.1 Key Findings
- 5.2 Therapeutics Segment: Market Attractiveness Index
- 5.3 Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
- 5.4 Oncology
- 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.4.2 Market Share by Region, 2023 & 2033 (%)
- 5.5 Immunology
- 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.5.2 Market Share by Region, 2023 & 2033 (%)
- 5.6 Diabetes
- 5.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.6.2 Market Share by Region, 2023 & 2033 (%)
- 5.7 Cardiovascular Disease
- 5.7.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.7.2 Market Share by Region, 2023 & 2033 (%)
- 5.8 Respiratory
- 5.8.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.8.2 Market Share by Region, 2023 & 2033 (%)
- 5.9 CNS
- 5.9.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.9.2 Market Share by Region, 2023 & 2033 (%)
- 5.10 Others
- 5.10.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.10.2 Market Share by Region, 2023 & 2033 (%)
6 Pharma Contract Sales Market Analysis by Region
- 6.1 Key Findings
- 6.2 Regional Market Size Estimation and Forecast
7 North America Pharma Contract Sales Market Analysis
- 7.1 Key Findings
- 7.2 North America Pharma Contract Sales Market Attractiveness Index
- 7.3 North America Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
- 7.4 North America Pharma Contract Sales Market Size Estimation and Forecast by Country
- 7.5 North America Pharma Contract Sales Market Size Estimation and Forecast by Type
- 7.5.1 North America Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
- 7.5.2 North America Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
- 7.5.3 North America Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
- 7.6 North America Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
- 7.7 U.S. Pharma Contract Sales Market Analysis
- 7.8 Canada Pharma Contract Sales Market Analysis
8 Europe Pharma Contract Sales Market Analysis
- 8.1 Key Findings
- 8.2 Europe Pharma Contract Sales Market Attractiveness Index
- 8.3 Europe Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
- 8.4 Europe Pharma Contract Sales Market Size Estimation and Forecast by Country
- 8.5 Europe Pharma Contract Sales Market Size Estimation and Forecast by Type
- 8.5.1 Europe Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
- 8.5.2 Europe Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
- 8.5.3 Europe Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
- 8.6 Europe Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
- 8.7 Germany Pharma Contract Sales Market Analysis
- 8.8 France Pharma Contract Sales Market Analysis
- 8.9 UK Pharma Contract Sales Market Analysis
- 8.10 Italy Pharma Contract Sales Market Analysis
- 8.11 Spain Pharma Contract Sales Market Analysis
- 8.12 Russia Pharma Contract Sales Market Analysis
- 8.13 Rest of Europe Pharma Contract Sales Market Analysis
9 Asia Pacific Pharma Contract Sales Market Analysis
- 9.1 Key Findings
- 9.2 Asia Pacific Pharma Contract Sales Market Attractiveness Index
- 9.3 Asia Pacific Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
- 9.4 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Country
- 9.5 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Type
- 9.5.1 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
- 9.5.2 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
- 9.5.3 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
- 9.6 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
- 9.7 Japan Pharma Contract Sales Market Analysis
- 9.8 China Pharma Contract Sales Market Analysis
- 9.9 India Pharma Contract Sales Market Analysis
- 9.10 Australia Pharma Contract Sales Market Analysis
- 9.11 South Korea Pharma Contract Sales Market Analysis
- 9.12 Rest of Asia Pacific Pharma Contract Sales Market Analysis
10 Latin America Pharma Contract Sales Market Analysis
- 10.1 Key Findings
- 10.2 Latin America Pharma Contract Sales Market Attractiveness Index
- 10.3 Latin America Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
- 10.4 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Country
- 10.5 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Type
- 10.5.1 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
- 10.5.2 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
- 10.5.3 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
- 10.6 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
- 10.7 Brazil Pharma Contract Sales Market Analysis
- 10.8 Mexico Pharma Contract Sales Market Analysis
- 10.9 Rest of Latin America Pharma Contract Sales Market Analysis
11 MEA Pharma Contract Sales Market Analysis
- 11.1 Key Findings
- 11.2 MEA Pharma Contract Sales Market Attractiveness Index
- 11.3 MEA Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
- 11.4 MEA Pharma Contract Sales Market Size Estimation and Forecast by Country
- 11.5 MEA Pharma Contract Sales Market Size Estimation and Forecast by Type
- 11.5.1 MEA Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
- 11.5.2 MEA Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
- 11.5.3 MEA Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
- 11.6 MEA Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
- 11.7 GCC Pharma Contract Sales Market Analysis
- 11.8 South Africa Pharma Contract Sales Market Analysis
- 11.9 Rest of MEA Pharma Contract Sales Market Analysis
12 Company Profiles
- 12.1 Competitive Landscape, 2022
- 12.2 Strategic Outlook
- 12.3 CMIC HOLDINGS Co., LTD.
- 12.3.1 Company Snapshot
- 12.3.2 Company Overview
- 12.3.3 Financial Analysis
- 12.3.3.1 Net Revenue, 2017-2022
- 12.3.4 Solution Benchmarking
- 12.3.5 Strategic Outlook
- 12.4 IQVIA Inc.
- 12.4.1 Company Snapshot
- 12.4.2 Company Overview
- 12.4.3 Financial Analysis
- 12.4.3.1 Net Revenue, 2017-2022
- 12.4.3.2 Regional Market Shares, 2022
- 12.4.4 Solution Benchmarking
- 12.4.5 Strategic Outlook
- 12.5 Syneos Health
- 12.5.1 Company Snapshot
- 12.5.2 Company Overview
- 12.5.3 Financial Analysis
- 12.5.3.1 Net Revenue, 2017-2022
- 12.5.3.2 Regional Market Shares, 2022
- 12.5.4 Solution Benchmarking
- 12.5.5 Strategic Outlook
- 12.6 Inizio Group Limited
- 12.6.1 Company Snapshot
- 12.6.2 Company Overview
- 12.6.3 Financial Analysis
- 12.6.3.1 Net Revenue, 2017-2022
- 12.6.3.2 Regional Market Shares, 2022
- 12.6.4 Solution Benchmarking
- 12.6.5 Strategic Outlook
- 12.7 Uniphar Group Plc
- 12.7.1 Company Snapshot
- 12.7.2 Company Overview
- 12.7.3 Financial Analysis
- 12.7.3.1 Net Revenue, 2017-2022
- 12.7.4 Solution Benchmarking
- 12.7.5 Strategic Outlook
- 12.8 ICON plc
- 12.8.1 Company Snapshot
- 12.8.2 Company Overview
- 12.8.3 Financial Analysis
- 12.8.3.1 Net Revenue, 2017-2022
- 12.8.3.2 Regional Market Shares, 2022
- 12.8.4 Solution Benchmarking
- 12.9 Amplity Health
- 12.9.1 Company Snapshot
- 12.9.2 Company Overview
- 12.9.3 Solution Benchmarking
- 12.9.4 Strategic Outlook
- 12.10 Apodi
- 12.10.1 Company Snapshot
- 12.10.2 Company Overview
- 12.10.3 Solution Benchmarking
- 12.11 Marvecs GmbH
- 12.11.1 Company Snapshot
- 12.11.2 Company Overview
- 12.11.3 Solution Benchmarking
- 12.11.4 Strategic Outlook
- 12.12 ONCALL, LLC.
- 12.12.1 Company Snapshot
- 12.12.2 Company Overview
- 12.12.3 Solution Benchmarking
- 12.13 PUBLICIS GROUPE
- 12.13.1 Company Snapshot
- 12.13.2 Company Overview
- 12.13.3 Financial Analysis
- 12.13.3.1 Net Revenue, 2017-2022
- 12.13.3.2 Regional Market Shares, 2022
- 12.13.4 Solution Benchmarking
- 12.13.5 Strategic Outlook
- 12.14 SOFIP
- 12.14.1 Company Snapshot
- 12.14.2 Company Overview
- 12.14.3 Solution Benchmarking
- 12.15 Granard Pharmaceutical Sales & Marketing
- 12.15.1 Company Snapshot
- 12.15.2 Company Overview
- 12.15.3 Solution Benchmarking
- 12.16 Vanguard Pharma
- 12.16.1 Company Snapshot
- 12.16.2 Company Overview
- 12.16.3 Solution Benchmarking
- 12.17 GTS Solution
- 12.17.1 Company Snapshot
- 12.17.2 Company Overview
- 12.17.3 Solution Benchmarking
- 12.18 MaBiCo
- 12.18.1 Company Snapshot
- 12.18.2 Company Overview
- 12.18.3 Solution Benchmarking
- 12.19 Sales Partnerships, Inc.
- 12.19.1 Company Snapshot
- 12.19.2 Company Overview
- 12.19.3 Solution Benchmarking
- 12.20 QFR Solution
- 12.20.1 Company Snapshot
- 12.20.2 Company Overview
- 12.20.3 Solution Benchmarking
13 Conclusion and Recommendations
- 13.1 Concluding Remarks from Visiongain
- 13.2 Recommendations for Market Players
Product Code: PHA1294
List of Tables
- Table 1 Pharma Contract Sales Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
- Table 2 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
- Table 3 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
- Table 4 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
- Table 5 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
- Table 6 Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 7 Personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 8 Promotional Sales Team Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 9 Vacancy Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 10 Health Care Professional Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 11 Non-personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 12 Contact Centre Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 13 Tele-detailing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 14 Medical Call Centres Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 15 Telesampling Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 16 Online Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 17 Co-promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 18 Marketing Research and Consulting Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 19 Product Commercialization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 20 Territory Optimization & Alignment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 21 Brand Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 22 Mature Product Line Support Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 23 Rest All CSO Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 24 Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 25 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 26 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 27 Diabetes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 28 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 29 Respiratory Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 30 CNS Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 31 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 32 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 33 North America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 34 North America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 35 North America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 36 North America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 37 North America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 38 North America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 39 U.S. Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 40 Canada Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 41 Europe Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 42 Europe Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 43 Europe Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 44 Europe Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 45 Europe Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 46 Europe Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 47 Germany Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 48 France Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 49 UK Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 50 Italy Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 51 Spain Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 52 Russia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 53 Rest of Europe Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 54 Asia Pacific Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 55 Asia Pacific Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 56 Asia Pacific Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 57 Asia Pacific Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 58 Asia Pacific Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 59 Asia Pacific Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 60 Japan Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 61 China Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 62 India Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 63 Australia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 64 South Korea Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 65 Rest of Asia Pacific Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 66 Latin America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 67 Latin America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 68 Latin America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 69 Latin America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 70 Latin America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 71 Latin America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 72 Brazil Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 73 Mexico Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 74 Rest of Latin America Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 75 MEA Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 76 MEA Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 77 MEA Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 78 MEA Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 79 MEA Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 80 MEA Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
- Table 81 GCC Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 82 South Africa Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 83 Rest of MEA Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
- Table 84 Strategic Outlook
- Table 85 CMIC HOLDINGS Co., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 86 CMIC Holdings Co., Ltd.: Solution Benchmarking
- Table 87 CMIC Holdings Co., Ltd.: Strategic Outlook
- Table 88 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 89 IQVIA Inc.: Solution Benchmarking
- Table 90 IQVIA Inc.: Strategic Outlook
- Table 91 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 92 Syneos Health: Solution Benchmarking
- Table 93 Syneos Health: Strategic Outlook
- Table 94 Inizio Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 95 Inizio Group Limited: Solution Benchmarking
- Table 96 Inizio Group Limited: Strategic Outlook
- Table 97 Uniphar Group Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 98 Uniphar Group Plc: Solution Benchmarking
- Table 99 Uniphar Group Plc: Strategic Outlook
- Table 100 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 101 ICON plc: Solution Benchmarking
- Table 102 Amplity Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 103 Amplity Health: Solution Benchmarking
- Table 104 Amplity Health: Strategic Outlook
- Table 105 Apodi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 106 Apodi: Solution Benchmarking
- Table 107 Marvecs GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 108 Marvecs GmbH: Solution Benchmarking
- Table 109 Marvecs GmbH: Strategic Outlook
- Table 110 ONCALL, LLC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 111 ONCALL, LLC.: Solution Benchmarking
- Table 112 PUBLICIS GROUPE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 113 PUBLICIS GROUPE: Solution Benchmarking
- Table 114 PUBLICIS GROUPE: Strategic Outlook
- Table 115 SOFIP: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 116 SOFIP: Solution Benchmarking
- Table 117 Granard Pharmaceutical Sales & Marketing: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 118 Granard Pharmaceutical Sales & Marketing: Solution Benchmarking
- Table 119 Vanguard Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 120 Vanguard Pharma: Solution Benchmarking
- Table 121 GTS Solution: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 122 GTS Solution: Solution Benchmarking
- Table 123 MaBiCo: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 124 MaBiCo: Solution Benchmarking
- Table 125 Sales Partnerships, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 126 Sales Partnerships, Inc.: Solution Benchmarking
- Table 127 QFR Solution: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 128 QFR Solution: Solution Benchmarking
List of Figures
- Figure 1 Pharma Contract Sales Market Segmentation
- Figure 2 Pharma Contract Sales Market by Type: Market Attractiveness Index
- Figure 3 Pharma Contract Sales Market by Therapeutics: Market Attractiveness Index
- Figure 4 Pharma Contract Sales Market Attractiveness Index by Region
- Figure 5 Pharma Contract Sales Market: Market Dynamics
- Figure 6 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): "V" Shaped Recovery
- Figure 7 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): "U" Shaped Recovery
- Figure 8 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): "W" Shaped Recovery
- Figure 9 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): "L" Shaped Recovery
- Figure 10 Pharma Contract Sales Market: Porter's Five Forces Analysis
- Figure 11 Pharma Contract Sales Market: PEST Analysis
- Figure 12 Pharma Contract Sales Market by Type: Market Attractiveness Index
- Figure 13 Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
- Figure 14 Pharma Contract Sales Market Share Forecast by Type, 2023, 2028, 2033 (%)
- Figure 15 Personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 16 Personal Promotion Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 17 Promotional Sales Team Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 18 Promotional Sales Team Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 19 Vacancy Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 20 Vacancy Management Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 21 Health Care Professional Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 22 Health Care Professional Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 23 Non-personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 24 Non-personal Promotion Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 25 Contact Centre Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 26 Contact Centre Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 27 Tele-detailing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 28 Tele-detailing Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 29 Medical Call Centres Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 30 Medical Call Centres Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 31 Telesampling Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 32 Telesampling Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 33 Online Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 34 Online Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 35 Co-promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 36 Co-promotion Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 37 Marketing Research and Consulting Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 38 Marketing Research and Consulting Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 39 Product Commercialization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 40 Product Commercialization Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 41 Territory Optimization & Alignment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 42 Territory Optimization & Alignment Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 43 Brand Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 44 Brand Management Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 45 Mature Product Line Support Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 46 Mature Product Line Support Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 47 Rest All CSO Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 48 Rest All CSO Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 49 Pharma Contract Sales Market by Therapeutics: Market Attractiveness Index
- Figure 50 Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
- Figure 51 Pharma Contract Sales Market Share Forecast by Therapeutics, 2023, 2028, 2033 (%)
- Figure 52 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 53 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 54 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 55 Immunology Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 56 Diabetes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 57 Diabetes Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 58 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 59 Cardiovascular Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 60 Respiratory Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 61 Respiratory Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 62 CNS Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 63 CNS Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 64 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
- Figure 65 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
- Figure 66 Pharma Contract Sales Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
- Figure 67 Pharma Contract Sales Market Share Forecast by Region 2023, 2028, 2033 (%)
- Figure 68 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %)
- Figure 69 North America Pharma Contract Sales Market Attractiveness Index
- Figure 70 North America Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
- Figure 71 North America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
- Figure 72 North America Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
- Figure 73 North America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
- Figure 74 North America Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
- Figure 75 North America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
- Figure 76 North America Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
- Figure 77 North America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
- Figure 78 North America Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
- Figure 79 North America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
- Figure 80 North America Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
- Figure 81 North America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
- Figure 82 North America Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
- Figure 83 U.S. Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 84 Canada Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 85 Europe Pharma Contract Sales Market Attractiveness Index
- Figure 86 Europe Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
- Figure 87 Europe Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
- Figure 88 Europe Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
- Figure 89 Europe Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
- Figure 90 Europe Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
- Figure 91 Europe Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
- Figure 92 Europe Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
- Figure 93 Europe Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
- Figure 94 Europe Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
- Figure 95 Europe Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
- Figure 96 Europe Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
- Figure 97 Europe Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
- Figure 98 Europe Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
- Figure 99 Germany Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 100 France Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 101 UK Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 102 Italy Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 103 Spain Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 104 Russia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 105 Rest of Europe Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 106 Asia Pacific Pharma Contract Sales Market Attractiveness Index
- Figure 107 Asia Pacific Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
- Figure 108 Asia Pacific Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
- Figure 109 Asia Pacific Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
- Figure 110 Asia Pacific Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
- Figure 111 Asia Pacific Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
- Figure 112 Asia Pacific Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
- Figure 113 Asia Pacific Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
- Figure 114 Asia Pacific Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
- Figure 115 Asia Pacific Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
- Figure 116 Asia Pacific Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
- Figure 117 Asia Pacific Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
- Figure 118 Asia Pacific Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
- Figure 119 Asia Pacific Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
- Figure 120 Japan Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 121 China Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 122 India Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 123 Australia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 124 South Korea Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 125 Rest of Asia Pacific Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 126 Latin America Pharma Contract Sales Market Attractiveness Index
- Figure 127 Latin America Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
- Figure 128 Latin America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
- Figure 129 Latin America Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
- Figure 130 Latin America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
- Figure 131 Latin America Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
- Figure 132 Latin America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
- Figure 133 Latin America Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
- Figure 134 Latin America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
- Figure 135 Latin America Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
- Figure 136 Latin America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
- Figure 137 Latin America Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
- Figure 138 Latin America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
- Figure 139 Latin America Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
- Figure 140 Brazil Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 141 Mexico Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 142 Rest of Latin America Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 143 MEA Pharma Contract Sales Market Attractiveness Index
- Figure 144 MEA Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
- Figure 145 MEA Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
- Figure 146 MEA Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
- Figure 147 MEA Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
- Figure 148 MEA Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
- Figure 149 MEA Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
- Figure 150 MEA Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
- Figure 151 MEA Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
- Figure 152 MEA Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
- Figure 153 MEA Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
- Figure 154 MEA Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
- Figure 155 MEA Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
- Figure 156 MEA Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
- Figure 157 GCC Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 158 South Africa Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 159 Rest of MEA Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
- Figure 160 Pharma Contract Sales Market: Company Share/Ranking, 2022
- Figure 161 CMIC Holdings Co., Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
- Figure 162 IQVIA Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
- Figure 163 IQVIA Inc.: Regional Market Shares, 2022
- Figure 164 Syneos Health: Net Revenue, 2017-2022 (US$ Billion, AGR%)
- Figure 165 Syneos Health: Regional Market Shares, 2022
- Figure 166 Inizio Group Limited: Net Revenue, 2017-2022 (US$ Billion, AGR%)
- Figure 167 Inizio Group Limited: Regional Market Shares, 2022
- Figure 168 Uniphar Group Plc: Net Revenue, 2017-2022 (US$ Billion, AGR%)
- Figure 169 ICON plc: Net Revenue, 2017-2022 (US$ Billion, AGR%)
- Figure 170 ICON plc: Regional Market Shares, 2022
- Figure 171 PUBLICIS GROUPE: Net Revenue, 2017-2022 (US$ Billion, AGR%)
- Figure 172 PUBLICIS GROUPE: Regional Market Shares, 2022
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.